RBC Capital analyst Christopher Carril maintains McDonald’s (NYSE:MCD) with a Outperform and raises the price target from $263 to $268.
Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Brian M Strem, Ph.D., President and Chief Executive Officer, will provide an outlook for the busines and its pipeline of treatments for ophthalmic diseases.
